98434-06-1 Usage
Uses
Used in Pharmaceutical Industry:
5-(2-Furyl)isoxazole-3-carboxylic acid is used as a building block for the development of new pharmaceutical compounds. Its presence of the furan group and carboxylic acid functionality allows for further modification and diversification to generate new compounds with desired properties and activities, making it a valuable asset in drug discovery and design.
Used in Organic Synthesis:
In the field of organic synthesis, 5-(2-Furyl)isoxazole-3-carboxylic acid serves as a versatile intermediate for the synthesis of various organic compounds. Its unique structure and reactivity enable the formation of a wide range of derivatives, expanding the scope of chemical reactions and applications.
Used in Agrochemical Industry:
5-(2-Furyl)isoxazole-3-carboxylic acid is also utilized in the agrochemical industry for the preparation of various agrochemicals. Its potential as a building block for the development of new agrochemical compounds can contribute to the creation of more effective and environmentally friendly products.
Used in the Preparation of Derivatives and Analogs:
5-(2-Furyl)isoxazole-3-carboxylic acid is used as a starting material for the preparation of various derivatives and analogs. Its unique structure allows for the generation of new compounds with specific properties and activities, which can be applied in different fields, including pharmaceuticals, agrochemicals, and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 98434-06-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,4,3 and 4 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 98434-06:
(7*9)+(6*8)+(5*4)+(4*3)+(3*4)+(2*0)+(1*6)=161
161 % 10 = 1
So 98434-06-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H5NO4/c10-8(11)5-4-7(13-9-5)6-2-1-3-12-6/h1-4H,(H,10,11)
98434-06-1Relevant articles and documents
ATF6 INHIBITORS AND USES THEREOF
-
, (2019/10/29)
Compounds as inhibitors of Activating Transcription Factor 6 (ATF6) are provided. The compounds may find use as therapeutic agents for the treatment of diseases or disorders mediated by ATF6 and may find particular use in the treatment of viral infections, neurodegenerative diseases, vascular diseases, or cancer.
PHARMACEUTICAL COMPOSITION FOR PREVENTINTION AND TREATMENT OF RESTENOSIS COMPRISING ISOXAZOLE DERIVATIVES
-
Page/Page column 18, (2009/03/07)
There is provided a pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives. The pharmaceutical composition includes a therapeutic effective amount of isoxazole derivatives represented by Formula 1 or pharmaceutically available salts thereof. The pharmaceutical composition may be useful to prevent and treat vascular restenosis since the pharmaceutical composition shows an anti-restenosis activity and accelerates the re-endothelization.
ISOXAZOLE DERIVATIVES AND USE THEREOF
-
Page/Page column 12, (2009/05/28)
Disclosed herein are isoxazole derivatives and uses thereof. Serving as agonists of Wnt, the isoxazole derivatives activate Wnt/beta-catenin signaling and thus can be used in the treatment and prevention of diseases related to the signal transduction. Also, pharmaceutically acceptable salts of the isoxazole derivatives are disclosed
ISOXAZOLE DERIVATIVES AND USE THEREOF
-
Page/Page column 36, (2010/11/28)
Disclosed herein are isoxazole derivaties and uses thereof. Serving as agonists of Wnt, the isoxazole derivatives activate Wnt/β-catenin signaling and thus can be used in the treatment and prevention of diseases related to the signal transduction. Also, pharmaceutically acceptable salts of the isoxazole derivatives are disclosed.
